Liver transplantation for hepatocellular carcinoma: A model including α-fetoprotein improves the performance of milan criteria

Gastroenterology

Volumn 143, Issue 4, 2012, Pages

  Duvoux, Christophe ^a,b   Roudot Thoraval, Françoise ^a,b   Decaens, Thomas ^a,b,c   Pessione, Fabienne ^d   Badran, Hanaa ^a   Piardi, Tullio ^e   Francoz, Claire ^f   Compagnon, Philippe ^g   Vanlemmens, Claire ^h   Dumortier, Jérome ⁱ   Dharancy, Sébastien ^j   Gugenheim, Jean ^k   Bernard, Pierre Henri ^l   Adam, René ^m   Radenne, Sylvie ⁿ   Muscari, Fabrice ^o   Conti, Filomena ^p   Hardwigsen, Jean ^q   Pageaux, Georges Philippe ^r   Chazouillères, Olivier ^p   Salame, Ephrem ^s   Hilleret, Marie Noelle ^t   Lebray, Pascal ^u   Abergel, Armand ^v   Debette Gratien, Marilyne ^w   Kluger, Michael D ^a   Mallat, Ariane ^a,b,c   Azoulay, Daniel ^a,b   Cherqui, Daniel ^a,b   more..

^a HENRI MONDOR HOSPITAL   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c INSERM U955   (France)

^d Direction médicale et scientifique Agence de la biomédecine   (France)

^e HÔPITAL DE HAUTEPIERRE   (France)

^f BEAUJON HOSPITAL   (France)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

ⁱ Hospices Civiles de Lyon   (France)

^j LILLE UNIVERSITY HOSPITAL   (France)

^k CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

^l HÔPITAL SAINT ANDRÉ   (France)

^m HÔPITAL PAUL BROUSSE   (France)

ⁿ CROIX ROUSSE HOSPITAL   (France)

^o CHU RANGUEIL   (France)

^p HÔPITAL SAINT ANTOINE   (France)

^q HÔPITAL DE LA CONCEPTION   (France)

^r HÔPITAL SAINT ELOI   (France)

^s CHU CÔTE DE NACRE   (France)

^t GRENOBLE UNIVERSITY HOSPITAL   (France)

^u PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^v UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^w LIMOGES UNIVERSITY HOSPITAL   (France)

more..

Author keywords

AFP; Hepatocellular Carcinoma; Liver Transplantation

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CANCER INVASION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SIZE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; TUMOR DIFFERENTIATION; VALIDATION STUDY;

EID: 84866661783     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.05.052     Document Type: Article

References (38)

1. J. Neuberger, O. James Guidelines for selection of patients for liver transplantation in the era of donor-organ shortage Lancet 354 1999 1636 1639
2. V. Mazzaferro, E. Regalia, R. Doci Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693 699
3. C. Toso, J. Trotter, A. Wei Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma Liver Transpl 14 2008 1107 1115
4. F.Y. Yao, L. Xiao, N.M. Bass Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging Am J Transplant 7 2007 2587 2596
5. T. Ito, Y. Takada, M. Ueda Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation Liver Transpl 13 2007 1637 1644
6. J.I. Herrero, B. Sangro, F. Pardo Liver transplantation in patients with hepatocellular carcinoma across Milan criteria Liver Transpl 14 2008 272 278
7. N. Onaca, G.L. Davis, R.M. Goldstein Expanded criteria for liver transplantation in patients with hepatocellular carcinoma: a report from the International Registry of Hepatic Tumors in Liver Transplantation Liver Transpl 13 2007 391 399
8. N.M. Kneteman, J. Oberholzer, M. Al Saghier Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinoma Liver Transpl 10 2004 1301 1311
9. V. Mazzaferro, J.M. Llovet, R. Miceli Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis Lancet Oncol 10 2009 35 43
10. G.N. Ioannou, J.D. Perkins, R.L. Carithers Jr Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival Gastroenterology 134 2008 1342 1351
11. S. Chevret, J.C. Trinchet, D. Mathieu A new prognostic classification for predicting survival in patients with hepatocellular carcinoma Groupe d'Etude et de Traitement du Carcinome Hepatocellulaire J Hepatol 31 1999 133 141
12. F. Farinati, M. Rinaldi, S. Gianni How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system Cancer 89 2000 2266 2273
13. F.Y. Yao, L. Ferrell, N.M. Bass Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival Hepatology 33 2001 1394 1403
14. T. Decaens, F. Roudot-Thoraval, S. Bresson-Hadni Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma Liver Transpl 11 2005 767 775
15. T. Decaens, F. Roudot-Thoraval, S. Bresson-Hadni Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patients World J Gastroenterol 12 2006 7319 7325
16. T. Decaens, F. Roudot-Thoraval, S. Hadni-Bresson Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time Liver Transpl 12 2006 1761 1769
17. H.A. Edmondson, P.E. Steiner Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies Cancer 7 1954 462 503
18. J.M. Llovet, A.M. Di Bisceglie, J. Bruix Design and endpoints of clinical trials in hepatocellular carcinoma J Natl Cancer Inst 100 2008 698 711
19. M.J. Pencina, R.B. D'Agostino Sr, R.B. D'Agostino Jr Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond Stat Med 27 2008 157 172 discussion, 207-212
20. L. De Carlis, A. Giacomoni, V. Pirotta Surgical treatment of hepatocellular cancer in the era of hepatic transplantation J Am Coll Surg 196 2003 887 897
21. K. Han, G.N. Tzimas, J.S. Barkun Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation Can J Gastroenterol 21 2007 39 45
22. M. Ravaioli, G. Ercolani, M. Cescon Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria Liver Transpl 10 2004 1195 1202
23. K. Shetty, K. Timmins, C. Brensinger Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome Liver Transpl 10 2004 911 918
24. M. Vivarelli, A. Cucchetti, F. Piscaglia Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression Liver Transpl 11 2005 497 503
25. M. Zhang, B. Li, L.N. Yan Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B World J Gastroenterol 14 2008 1280 1285
26. N.F. Esnaola, G.Y. Lauwers, N.Q. Mirza Predictors of microvascular invasion in patients with hepatocellular carcinoma who are candidates for orthotopic liver transplantation J Gastrointest Surg 6 2002 224 232 discussion, 232
27. S. Jonas, W.O. Bechstein, T. Steinmuller Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080 1086
28. G.B. Klintmalm Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome Ann Surg 228 1998 479 490
29. A. Plessier, L. Codes, Y. Consigny Underestimation of the influence of satellite nodules as a risk factor for post-transplantation recurrence in patients with small hepatocellular carcinoma Liver Transpl 10 2004 S86 S90
30. S. Tamura, T. Kato, M. Berho Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation Arch Surg 136 2001 25 30
31. J.W. Marsh, S.D. Finkelstein, A.J. Demetris Genotyping of hepatocellular carcinoma in liver transplant recipients adds predictive power for determining recurrence-free survival Liver Transpl 9 2003 664 671
32. V.R. Mas, R.A. Fisher, K.J. Archer Genes associated with progression and recurrence of hepatocellular carcinoma in hepatitis C patients waiting and undergoing liver transplantation: preliminary results Transplantation 83 2007 973 981
33. V.R. Mas, D.G. Maluf, K.J. Archer Differentially expressed genes between early and advanced hepatocellular carcinoma (HCC) as a potential tool for selecting liver transplant recipients Mol Med 12 2006 97 104
34. M. Schwartz, I. Dvorchik, S. Roayaie Liver transplantation for hepatocellular carcinoma: extension of indications based on molecular markers J Hepatol 49 2008 581 588
35. M. Fujioka, Y. Nakashima, O. Nakashima Immunohistologic study on the expressions of alpha-fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma Hepatology 34 2001 1128 1134
36. C.H. Kwon, D.J. Kim, Y.S. Han HCC in living donor liver transplantation: can we expand the Milan criteria? Dig Dis 25 2007 313 319
37. C. Toso, S. Asthana, D.L. Bigam Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database Hepatology 49 2009 832 838
38. S.S. Zheng, X. Xu, J. Wu Liver transplantation for hepatocellular carcinoma: Hangzhou experiences Transplantation 85 2008 1726 1732